QD
Therapeutic Areas
RayThera Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Anti-Inflammatory 1 | Anti-Inflammatory | Lead Generation/Optimization |
| Anti-Inflammatory 2 | Anti-Inflammatory | Lead Generation/Optimization |
| Anti-Inflammatory 3 | Anti-Inflammatory | Lead Generation/Optimization |
Leadership Team at RayThera
GH
Gene Hung
Co-Founder, Chief Science Officer
KF
Kyle Fraher
Senior Vice President, Development
MG
Mary Gieson
Vice President, Corporate Operations
JL
Jing Liu
Vice President, Technical Operations
JZ
Junhu Zhang
Vice President, Chemistry
XX
Xiaohua Xue
Vice President, Biology